Lack G - Search Results

1

Skin as the target for allergy prevention and treatment.

Marques-Mejias A, Bartha I, Ciaccio CE, Chinthrajah RS, Chan S, Hershey GKK, Hui-Beckman JW, Kost L, Lack G, Layhadi JA, Leung DYM, Marshall HF, Nadeau KC, Radulovic S, Rajcoomar R, Shamji MH, Sindher S, Brough HA. Marques-Mejias A, et al. Among authors: lack g. Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00001-2. doi: 10.1016/j.anai.2023.12.030. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 38253125 Free article. Review.

2

Inhibition of the development of immediate hypersensitivity by staphylococcal enterotoxin B.

Saloga J, Lack G, Bradley K, Renz H, Larsen G, Leung DY, Gelfand EW. Saloga J, et al. Among authors: lack g. Eur J Immunol. 1994 Dec;24(12):3140-7. doi: 10.1002/eji.1830241234. Eur J Immunol. 1994. PMID: 7805743

3

In vivo effects of glucocorticoids on IgE production.

Zieg G, Lack G, Harbeck RJ, Gelfand EW, Leung DY. Zieg G, et al. Among authors: lack g. J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):222-30. doi: 10.1016/0091-6749(94)90044-2. J Allergy Clin Immunol. 1994. PMID: 8064074

4

Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease.

Paterson RL, Lack G, Domenico JM, Delespesse G, Leung DY, Finkel TH, Gelfand EW. Paterson RL, et al. Among authors: lack g. Eur J Immunol. 1996 Sep;26(9):1979-84. doi: 10.1002/eji.1830260902. Eur J Immunol. 1996. PMID: 8814234

5

Preventing food allergy.

Khakoo A, Lack G. Khakoo A, et al. Among authors: lack g. Curr Allergy Asthma Rep. 2004 Jan;4(1):36-42. doi: 10.1007/s11882-004-0041-1. Curr Allergy Asthma Rep. 2004. PMID: 14680620 Review.

6

Epidemiologic risks for food allergy.

Lack G. Lack G. J Allergy Clin Immunol. 2008 Jun;121(6):1331-6. doi: 10.1016/j.jaci.2008.04.032. J Allergy Clin Immunol. 2008. PMID: 18539191 Review.

7

IgE-mediated facilitated antigen presentation underlies higher immune responses in peanut allergy.

Turcanu V, Stephens AC, Chan SM, Rancé F, Lack G. Turcanu V, et al. Among authors: lack g. Allergy. 2010 Oct;65(10):1274-81. doi: 10.1111/j.1398-9995.2010.02367.x. Epub 2010 Apr 7. Allergy. 2010. PMID: 20384616

8

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

Sampson HA, Leung DY, Burks AW, Lack G, Bahna SL, Jones SM, Wong DA. Sampson HA, et al. Among authors: lack g. J Allergy Clin Immunol. 2011 May;127(5):1309-10.e1. doi: 10.1016/j.jaci.2011.01.051. Epub 2011 Mar 11. J Allergy Clin Immunol. 2011. PMID: 21397314 Clinical Trial. No abstract available.

9

Cutaneous lymphocyte antigen and α4β7 T-lymphocyte responses are associated with peanut allergy and tolerance in children.

Chan SM, Turcanu V, Stephens AC, Fox AT, Grieve AP, Lack G. Chan SM, et al. Among authors: lack g. Allergy. 2012 Mar;67(3):336-42. doi: 10.1111/j.1398-9995.2011.02765.x. Allergy. 2012. PMID: 22423373

10

Update on risk factors for food allergy.

Lack G. Lack G. J Allergy Clin Immunol. 2012 May;129(5):1187-97. doi: 10.1016/j.jaci.2012.02.036. Epub 2012 Mar 30. J Allergy Clin Immunol. 2012. PMID: 22464642 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page